AMSbiopharma is the perfect CRO (Contract Research Organisation) partner of choice in the different stages of development of new biological or biopharmaceutical compounds, specifically in the activities of chemical and structural characterization of the compound (proteins, peptides, monoclonal antibodies, biosimilars, etc.), our main ally in this stage in terms of technology is mass spectrometry, which together with the qualification and equipment of our laboratory, allows us to offer a complete catalog of services for the characterization and analysis of biologicals. In addition, we can optimize, fine-tune and validate methods for raw materials in the Quality Control stages, especially with pharmacopeia methods (USP, EP), as well as elemental impurity analysis by ICP-MS (ICH Q3D). Our services also extend to the small molecule pharmaceutical sector, offering tailor-made services for the identification, characterization, and quantification of impurities and unknown substances in small molecules.

Business areas: 

Chemical and pharmaceutical industry.

Business lines: 

Pharmaceutical sector
Biopharmaceutical sector